Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology

Ciência & Saúde Coletiva

Isabel Cristina Martins Emmerick²  Vera Lucia Luiza²  Vera Lucia Edais Pepe¹ 

[1] ,Fundação Oswaldo Cruz Escola Nacional de Saúde Pública Departamento de Ciências BiológicasRio de Janeiro RJ

关键词: Pharmaceutical services;    Pharmaceutical services evaluation;    Healthcare quality indicators;    Rational drug use;    Health policy;    Serviços farmacêuticos;    Avaliação de serviços farmacêuticos;    Indicadores de qualidade do cuidado de saúde;    Uso racional de medicamentos;    Políticas de saúde;   

DOI  :  10.1590/S1413-81232009000400036

来源: SciELO

【 摘 要 】

The objective of this paper is to explore and analyze the results of the Diagnosis of the Pharmaceutical Situation in Brazil (DiagAF-Br) from a regional perspective. The study made use of an exploratory approach of multiple cases based on the DiagAF-Br data collected in five Brazilian states. A descriptive analysis of selected indicators was performed in each of the Brazilian states in three pharmaceutical dimensions: access, quality, and rational use of medicines. The mainly results concerning the “percentage of completed prescriptions” varied from 1.1% in the State of Goiás to 98.6% in Espírito Santo; the “percentage of patients who know how to take their medicines” varied from 60.4% in Sergipe to 93.3% in Rio Grande do Sul. Educational level showed to be an important predictor of knowledge on how to use medicines, especially relevant when prescription is completed. The “average number of prescribed medicines”, approximately 2.1, did not show any difference between the visited sites. Different levels of management capacity and services organization were identified, suggesting the need for more adequate strategies to improve access, quality and mainly rational use of medicines in Brazil.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License